Skip to main content
NIH funding notice RFA-DA-24-017

Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional)

Closed on November 9, 2023.

Posted
May 23, 2023
Close date
November 9, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $285,707 in first-year total cost, median $285,707.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 CEM-S (M1)]1

Most frequent institutions

  1. MEANINGFUL MEASUREMENT, INC.1
Competing awards under RFA-DA-24-017 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Reentry-Assist App Development for Individuals with Addiction and Mental Illness1R41DA061403-01SMELSON, DAVID ATATUM, DONNAMEANINGFUL MEASUREMENT, INC., IN$285,707ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.